Healthpeak Properties, Inc. DOC ← Back to all reports

Healthpeak Properties, Inc.

DOC · Real Estate
A ★★★★ Buy
Nov 5, 2026 · Score 78 · Type A — Value-style analysis Used for established, cash-generative companies — weighs earnings power, valuation against the company's own history and peers, and margin of safety. Full methodology →
Current PriceThe market price around the time this report was written — not a live quote. The market has moved since; check a current price before acting.Methodology → $20.17
Buy ZoneThe large figure is the midpoint of the suggested buy range shown in parentheses. $18.50 ($18.00–$19.00)
Price TargetOur estimated fair value. For richly valued stocks it can sit below the current price — see Methodology.Methodology → $22.20
Expected Return
  • Target relative to the Current Price ((Target − Current) ÷ Current). Since that price is from the report date, your actual return will differ.
  • A negative Expected Return means the Price Target is below the report-date Current Price. This can occur even with a Buy or Strong Buy recommendation because recommendations follow a fixed mapping from the overall investment score, which combines business assessment, valuation and risk. This is a limitation of our score-based framework: a favorable recommendation does not always imply an attractive entry price. Consider the Price Target, Buy Zone and valuation analysis together.
Methodology →
+10.1%

Type A - Healthpeak Properties, Inc. (DOC) 20261105 Stock Analysis

📅 Healthpeak Key Upcoming Events

🏢 Step 1: Healthpeak Company Overview & Business Model

Q1-A1. What is Healthpeak?

Q1-A2. How Does Healthpeak Make Money?

Q1-A3. Healthpeak’s Revenue Segments & Core Income Sources

Q1-A4. Who Are Healthpeak’s Competitors?

Q1-A5. Healthpeak Key Events: Past 12 Months

Q1-A6. Step 1 Key Takeaways

🏰 Step 2: Healthpeak’s Economic Moat, Growth & Capital Allocation

Q2-A1. Does Healthpeak Have a Durable Economic Moat?

Q2-A2. Is Healthpeak’s Growth Sustainable?

Q2-A3. How Does Healthpeak Allocate Capital & Return Cash?

Q2-A4. Step 2 Key Takeaways

💰 Step 3: Is Healthpeak Profitable? Financial Health Analysis

Q3-A2. How Profitable Is Healthpeak? (Margins & ROIC)

Q3-A3. What Drives Healthpeak’s Returns? (ROIC Breakdown)

Q3-A4. Are Healthpeak’s Earnings High Quality?

Q3-A5. Is Healthpeak’s Balance Sheet Healthy? (Debt & Leverage)

Q3-A6. Step 3 Key Takeaways

🔎 Step 4: Healthpeak Forensic Accounting & Dilution Review

Q4-A1. Does Healthpeak Have Accounting Red Flags?

Q4-A2. Is Healthpeak Overspending? (Capex & Capital Cycle)

Q4-A3. How Sound Is Healthpeak’s Cash Flow?

Q4-A4. Is Healthpeak Diluting Shareholders?

Q4-A5. Data Integrity Check

Q4-A6. Step 4 Key Takeaways

👔 Step 5: Healthpeak Management & Shareholder Alignment

Q5-A1. Can You Trust Healthpeak’s Management? (Guidance Track Record)

Q5-A2. What Are Healthpeak Insiders Doing?

Q5-A3. Is Healthpeak’s Management Aligned With Shareholders?

Q5-A4. Step 5 Key Takeaways

⛵ Step 6: Healthpeak Market Flow & Sentiment

Q6-A1. Analyst Consensus vs Healthpeak Guidance

Q6-A2. What Is Healthpeak’s Short Interest?

Q6-A3. Step 6 Key Takeaways

🚀 Step 7: Healthpeak Catalysts & Price Triggers

Q7-A1. What Could Move Healthpeak Stock? (Top 3 Catalysts)

Q7-A2. Healthpeak’s Earnings Revision Trend

Q7-A3. Step 7 Key Takeaways

⚖️ Step 8: Is Healthpeak Fairly Valued? Valuation Analysis

Q8-A1. Healthpeak’s Key Valuation Multiples

Q8-A2. Healthpeak vs Peers: Valuation Comparison

Q8-A3. Is Healthpeak Cheap or Expensive vs Its History?

Q8-A4. What Growth Is Priced Into Healthpeak? (Reverse DCF)

Q8-A4-1. What Growth Hurdle Does the Market Demand From Healthpeak? (Reverse DCF Alternative)

Q8-A5. Healthpeak’s Hidden Asset & Stake Valuation

Q8-A6. Final Valuation Adjustment

Q8-A7. Valuation Adjustment Score Calculation

💀 Step 9: What Are the Risks of Healthpeak? Fatal Risks & Pre-Mortem

Q9-A1. What Are the Biggest Risks to Healthpeak?

Q9-A2. How Sensitive Is Healthpeak to the Economy?

Q9-A3. Healthpeak Pre-Mortem: What Could Go Wrong?

Q9-A4. Risk Adjustment Score

🎯 Step 10: Healthpeak Final Verdict: Score & Rating

Q10-A1. Investment Score & Rating

Q10-A2. Should You Buy Healthpeak? (Recommendation)

Q10-A3. Investment Thesis in One Line

Q10-A4. Healthpeak’s Price Trend & Key Drivers

Q10-A5. Action Plan

🕵️‍♂️ Deep Dive Analysis

Q1: Is Healthpeak’s Laboratory Portfolio Its Biggest Structural Weakness?

Q2: Can Healthpeak’s Approximately 11.4x Guided Adjusted FFO Valuation Be Justified?

Q3: Can Healthpeak Turn Laboratory Occupancy Improvements Into Sustainable NOI Growth?

Q4: Does Healthpeak’s Janus Living Stake Create Hidden Shareholder Value?

Q5: Can Healthpeak Maintain Its Monthly Dividend Through a Weaker Property Cycle?

Q6: Will Higher Interest Rates Permanently Limit Healthpeak’s Growth?

Q7: Is Healthpeak’s Brookfield Joint Venture Evidence of Strong Capital Allocation?

Q8: Can Healthpeak’s Senior Housing Expansion Sustain Its Recent NOI Growth?

Q9: Does Healthpeak’s Diversification Reduce Risk or Hide Conflicting Property Cycles?

Q10: What Would Make Healthpeak a Stronger Long-Term Compounder?

Rating History

Rating History shows the Rating assigned on each report date. Only the latest report is available to read. Scores are omitted from the timeline because reports from different periods may follow different rating scales.

  1. 2026-08 A
  2. 2026-10 A
  3. 2026-11 A